Skip to main content
General Medicine

Selumetinib



General

Pronunciation

(SEL ue ME ti nib)

Brand Names: U.S.

  • Koselugo

Indications

Use: Labeled Indications

Neurofibromatosis type 1: Treatment of neurofibromatosis type 1 in pediatric patients ≥2 years of age...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

START 10-DAY FREE TRIAL
Subscribe Now
©2025 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved.
Enter an Access Code
Enter the code from your copy of The 5-Minute Clinical Consult or another access code to create an account.
Redeem
×